DR Congo Ebola outbreak on track to become deadliest in history, WHO chief says
By Nana Karikari, Senior Global Affairs Correspondent
The current Ebola crisis in the Democratic Republic of Congo threatens to become the deadliest in recorded history. World Health Organization Director-General Tedros Adhanom Ghebreyesus addressed reporters with stark projections on Wednesday. He noted that the epidemic now moves at an alarming velocity. At its current pace, it is on track to eclipse the West African Ebola outbreak of 2014 to 2016. That historical crisis claimed at least 11,000 lives and shook the international scientific community.
A Hidden Beginning
Declared officially on May 15, the eastern Congo emergency already accounts for more than 4,300 cases and over 2,000 deaths. Genetic sequencing and new research reveal a troubling timeline. The pathogen began circulating quietly three months prior, in February. Early symptoms mimic malaria or typhoid, leading to initial misdiagnoses. Dr. Mohamed Janabi, WHO Africa director, spoke bluntly at a Bunia news conference. He admitted that “the outbreak had a big head start, still way ahead of us, and we’re playing catch-up.” He added that health teams are chasing the virus while the virus remains firmly ahead.
The Threat of a Rare Strain
This specific health emergency stems from the Bundibugyo species of Ebola. This rare strain previously caused only two documented outbreaks, occurring in 2007 and 2012. Unlike other strains, no approved vaccine or recognized therapeutic drugs exist to treat it. A recent study published in Nature Medicine suggests the outbreak originated from a zoonotic jump. The virus is genetically distinct from previous Bundibugyo strains. Transmission occurs through direct contact with infected bodily fluids like blood, vomit, or semen. Contaminated materials such as clothing and bedding also spread the contagion. Symptoms emerge rapidly within two to 21 days. They begin with sudden fever, headache, and fatigue. The illness quickly advances to severe vomiting, diarrhea, and catastrophic organ failure.
Compounding Crises on the Ground
Efforts to contain the virus face severe operational hurdles in eastern Congo. Ongoing regional instability and armed conflict complicate access for medical personnel. Poor infrastructure and ill-equipped local health centers further restrict response capabilities. Health workers currently reach only about thirty percent of active cases. Personnel strikes over unpaid wages have disrupted treatment facilities. Meanwhile, widespread misinformation breeds community distrust toward outside medical workers. Dr. Abdirahman Mahamud, WHO director for health emergency alert and response operations, outlined future trajectories. The agency projects the epidemiological peak within six months under moderate scenarios. Mahamud warned that “there is a one-case scenario where this outbreak may last nine months to 12 months.” The WHO hopes to reverse transmission trends within three months. Officials stressed this goal means controlling spread rather than ending the outbreak entirely.
Scientific Innovation and Trials
Global researchers are racing to deploy counter-measures against the Bundibugyo strain. The United Kingdom medicines regulator, the MHRA, authorized human trials for a new vaccine candidate. Developed by Oxford University researchers, the jab utilizes technology from the Oxford-AstraZeneca Covid vaccine. Three additional research groups are developing alternative vaccines for the same strain. Tedros confirmed that human trials for two vaccines developed specifically for the Bundibugyo virus began recently. The WHO also sponsors separate clinical trials in Ituri province. These trials test whether two existing antiviral therapies improve patient survival rates. Researchers are additionally studying whether conventional Ebola vaccines offer cross-protection. Animal studies for that approach have yielded promising preliminary results.
Regional Resilience and Cross-Border Coordination
Beyond central hospital wards, health ministries and regional partners across Central and East Africa have mobilized active cross-border surveillance frameworks to protect vulnerable transit hubs. Neighboring nations demonstrate that rapid contact tracing, community-led education, and prompt clinical isolation can successfully curb imported transmission chains before they take root locally. Public health specialists emphasize that defeating this epidemic depends entirely on supporting localized African health infrastructure and empowering frontline responders with the resources they need.
Navigating the Crisis Ahead
Navigating this unprecedented public health emergency requires sustained international solidarity, transparent data sharing, and robust community engagement to bridge the gap between frontline responders and vulnerable populations.
Related
Credit: Source link